New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also revealed certain unique features in especially young patients and those with predisposing conditions.
Although incidence and mortality rates of colorectal cancer have fallen in patients aged 50 years and older, early-onset colorectal cancer rates have been increasing over the past two decades. To look for differences between early-onset and late-onset colorectal cancer, investigators at The University of Texas MD Anderson Cancer Center in Houston analyzed information on more than 36,000 colorectal cancer patients.
The researchers found that younger patients were more likely to have certain genetic mutations and certain subtypes of colorectal cancer than older patients. Also, among patients with early-onset colorectal cancer, very young patients (aged 18-29 years) were unique from older patients (aged 30-49 years) in terms of the clinical and genetic features of their cancer. Likewise, patients with early-onset colorectal cancer who had predisposing conditions, such as inflammatory bowel disease, had different clinical and genetic characteristics compared with patients without predisposing conditions.
"We need to appreciate that there are unique biologic subtypes within young patients that may affect how their cancers behave and may require a personalized approach to treatment," said senior author Jonathan Loree, MD. "Going forward, special clinical consideration should be given to, and further scientific investigations should be performed for, both very young patients with colorectal cancer and those with predisposing medical conditions."
March is Colorectal Cancer Awareness Month.
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:
Penny Smith +44 (0) 1243 770448 (UK)
Josh Glickman +1 201-748-6572 (US)
Follow us on Twitter @WileyNews
"Clinical and Molecular Characterization of Early-Onset Colorectal Cancer. "Alexandra N. Willauer, Yusha Liu, Allan A.L. Pereira, Michael Lam, Jeffrey S. Morris, Kanwal P.S. Raghav, Van K. Morris, David Menter, Russell Broaddus, Funda Meric-Bernstam, Andrea Hayes-Jordan, Winston Huh, Michael J. Overman, Scott Kopetz, and Jonathan M. Loree. CANCER; Published Online: March 11, 2019 (DOI:10.1002/cncr.31994).
URL Upon Publication: http://doi.
The Media Specialists at MD Anderson Cancer Center can be contacted at 713-792-0655 or PublicRelations@mdanderson.org. Dr. Loree is now working at BC Cancer, whose media relations can be reached at 778-867-7472 or email@example.com. All other authors are still affiliated with MD Anderson.
About the Journal
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.
Follow us on Twitter @JournalCancer
Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company's website can be accessed at http://www.